For pharmaceutical manufacturers, ePrescribing is both a threat and an opportunity. The threat comes from the increased rate of generic prescribing and loss of leverage due to better formulary adherence. The major opportunities are from improved drug regimen compliance and access to real-time data.
A panel entitled "What Role Should Pharma Play in ePrescribing and the Point-of-Care?" at a recent ePharma Summit conference held in Philadelphia, PA, discussed the issues facing pharmaceutical companies as electronic prescribing (ePrescribing or eRx) threatens to upset the "balance of power" between physicians, pharma companies, and payers at the point-of-care.
- Questions for Pharma to Ponder
- Appropriate Messaging
- Best Practices
- Benefits to Pharma